Clinical trial
A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With…
NCT00405119 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00405119 |
|---|---|
| Title | A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. |
| Official title | A Randomized, Double-blind, Four Period Cross-over Comparison of the Effect of Two Doses Lavoltidine, Esomeprazole, and Placebo on 24 Hour Gastric pH and Frequency of Heartburn in Symptomatic GERD Subjects Without Esophageal Erosions |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease, Reflux, Gastroesophageal |
| Intervention type | Drug |
| Interventions | AH23844 (lavoltidine), NEXIUM (esomeprazole), ZANTAC (ranitidine) |
| Enrollment | 92 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 29, 2006 |
| Last update posted | Jan 19, 2017 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: